This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Innovations of Elizabeth Anne Dingess-Hammond
Introduction
Elizabeth Anne Dingess-Hammond is a notable inventor based in Indianapolis, IN (US). She has made significant contributions to the field of glycopeptide synthesis. Her work is particularly focused on the stereospecific synthesis of glycopeptides, which are essential in various biochemical applications.
Latest Patents
Elizabeth holds 1 patent for her invention titled "Glycopeptide and preparation thereof." This patent describes a method for the stereospecific synthesis of a glycopeptide using a triply orthogonal protection scheme. Specifically, it details the synthesis of N-acetylglucosaminyl-β-[1,4]-N-acetylmuramylmonopeptide and its derivatives. The glycopeptide produced is useful for the preparation of GMDP and related compounds that have a glucosaminyl-β-[1,4]-N-acetylmuramic acid disaccharide core.
Career Highlights
Elizabeth is currently employed at Eli Lilly and Company, where she continues to innovate in the field of pharmaceuticals. Her work has contributed to advancements in drug development and therapeutic applications.
Collaborations
Some of her notable coworkers include Larry C Blaszczak and William Joseph Hornback. Their collaborative efforts have further enhanced the research and development initiatives at Eli Lilly and Company.
Conclusion
Elizabeth Anne Dingess-Hammond is a pioneering inventor whose work in glycopeptide synthesis has significant implications in the pharmaceutical industry. Her contributions continue to influence advancements in drug development and biochemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile